Sarah Anderson
Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoglycemic Agents | 5 | 2020 | 1055 | 1.180 |
Why?
| Diabetes Mellitus, Type 2 | 7 | 2020 | 2221 | 0.970 |
Why?
| Professional Role | 3 | 2020 | 162 | 0.910 |
Why?
| Medication Therapy Management | 2 | 2020 | 73 | 0.850 |
Why?
| Pharmacists | 3 | 2022 | 245 | 0.800 |
Why?
| Internship, Nonmedical | 1 | 2021 | 18 | 0.790 |
Why?
| Sleep Initiation and Maintenance Disorders | 2 | 2014 | 141 | 0.770 |
Why?
| Outpatient Clinics, Hospital | 1 | 2021 | 84 | 0.760 |
Why?
| Glucagon-Like Peptides | 1 | 2020 | 22 | 0.730 |
Why?
| Pharmaceutical Services | 1 | 2020 | 80 | 0.710 |
Why?
| Education, Pharmacy | 1 | 2021 | 131 | 0.690 |
Why?
| Medication Reconciliation | 1 | 2018 | 25 | 0.640 |
Why?
| Insulin, Long-Acting | 1 | 2017 | 49 | 0.620 |
Why?
| Ambulatory Care | 1 | 2021 | 497 | 0.600 |
Why?
| 4-Hydroxycoumarins | 1 | 2016 | 6 | 0.590 |
Why?
| Dissociative Disorders | 1 | 2016 | 24 | 0.580 |
Why?
| Vitamin K | 1 | 2016 | 45 | 0.570 |
Why?
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2020 | 410 | 0.550 |
Why?
| Pharmacy Residencies | 1 | 2015 | 11 | 0.530 |
Why?
| Anticoagulants | 1 | 2019 | 589 | 0.510 |
Why?
| Atrial Fibrillation | 1 | 2019 | 392 | 0.500 |
Why?
| Dibenzothiazepines | 1 | 2014 | 20 | 0.490 |
Why?
| Personnel Selection | 1 | 2015 | 77 | 0.490 |
Why?
| Uterine Perforation | 1 | 2013 | 2 | 0.490 |
Why?
| Intrauterine Device Migration | 1 | 2013 | 3 | 0.480 |
Why?
| Patient Discharge | 2 | 2018 | 842 | 0.480 |
Why?
| Blood Coagulation Disorders | 1 | 2016 | 213 | 0.480 |
Why?
| Levonorgestrel | 1 | 2013 | 31 | 0.470 |
Why?
| Intrauterine Devices, Medicated | 1 | 2013 | 25 | 0.460 |
Why?
| Suicide, Attempted | 1 | 2016 | 331 | 0.460 |
Why?
| Contraceptive Agents, Female | 1 | 2013 | 65 | 0.450 |
Why?
| Interviews as Topic | 1 | 2015 | 601 | 0.440 |
Why?
| Diabetes Mellitus | 2 | 2020 | 985 | 0.430 |
Why?
| Venoms | 1 | 2012 | 33 | 0.430 |
Why?
| Pharmacy Service, Hospital | 1 | 2013 | 88 | 0.430 |
Why?
| Histamine H1 Antagonists | 1 | 2012 | 32 | 0.420 |
Why?
| Specialization | 1 | 2013 | 134 | 0.420 |
Why?
| Glucosides | 1 | 2012 | 39 | 0.420 |
Why?
| Antipsychotic Agents | 1 | 2014 | 197 | 0.410 |
Why?
| Postpartum Period | 1 | 2013 | 281 | 0.390 |
Why?
| Administration, Oral | 3 | 2020 | 786 | 0.390 |
Why?
| Hypnotics and Sedatives | 1 | 2012 | 146 | 0.380 |
Why?
| Continuity of Patient Care | 1 | 2013 | 276 | 0.380 |
Why?
| Stroke | 1 | 2019 | 1090 | 0.370 |
Why?
| Pancreatitis | 1 | 2010 | 112 | 0.350 |
Why?
| Glucagon-Like Peptide 1 | 1 | 2010 | 105 | 0.340 |
Why?
| Patient-Centered Care | 1 | 2013 | 513 | 0.310 |
Why?
| Peptides | 1 | 2012 | 893 | 0.290 |
Why?
| Heart Failure | 1 | 2018 | 2114 | 0.250 |
Why?
| Humans | 22 | 2022 | 122796 | 0.250 |
Why?
| Aspirin | 2 | 2015 | 344 | 0.210 |
Why?
| Platelet Aggregation Inhibitors | 2 | 2015 | 425 | 0.200 |
Why?
| Education, Distance | 1 | 2021 | 36 | 0.190 |
Why?
| Rural Health Services | 1 | 2021 | 108 | 0.180 |
Why?
| Middle Aged | 8 | 2020 | 28563 | 0.180 |
Why?
| Workflow | 1 | 2021 | 148 | 0.180 |
Why?
| Aged | 7 | 2020 | 20495 | 0.170 |
Why?
| Adult | 8 | 2021 | 32385 | 0.170 |
Why?
| Cardiovascular System | 1 | 2020 | 132 | 0.160 |
Why?
| Heart Valve Diseases | 1 | 2019 | 137 | 0.160 |
Why?
| Health Policy | 1 | 2021 | 356 | 0.160 |
Why?
| Antihypertensive Agents | 1 | 2021 | 465 | 0.150 |
Why?
| Randomized Controlled Trials as Topic | 2 | 2014 | 1260 | 0.150 |
Why?
| Female | 11 | 2021 | 63629 | 0.150 |
Why?
| Cohort Studies | 2 | 2020 | 5294 | 0.140 |
Why?
| Aged, 80 and over | 5 | 2016 | 6845 | 0.140 |
Why?
| Clinical Trials as Topic | 2 | 2012 | 985 | 0.140 |
Why?
| Patient Transfer | 1 | 2018 | 156 | 0.140 |
Why?
| Pandemics | 2 | 2022 | 1401 | 0.140 |
Why?
| Follow-Up Studies | 2 | 2016 | 4768 | 0.130 |
Why?
| Treatment Outcome | 2 | 2020 | 9692 | 0.130 |
Why?
| Body Weight | 1 | 2020 | 958 | 0.130 |
Why?
| Heart Failure, Diastolic | 1 | 2015 | 22 | 0.130 |
Why?
| Migraine Disorders | 1 | 2016 | 81 | 0.130 |
Why?
| Quetiapine Fumarate | 1 | 2014 | 28 | 0.120 |
Why?
| Medically Underserved Area | 1 | 2015 | 104 | 0.120 |
Why?
| Hypertension | 2 | 2021 | 1245 | 0.120 |
Why?
| Health Care Costs | 1 | 2017 | 414 | 0.120 |
Why?
| Medical Marijuana | 1 | 2016 | 103 | 0.120 |
Why?
| Eating | 1 | 2016 | 379 | 0.120 |
Why?
| Blood Glucose | 2 | 2012 | 1957 | 0.110 |
Why?
| Schools, Pharmacy | 1 | 2013 | 53 | 0.110 |
Why?
| Telemedicine | 1 | 2021 | 691 | 0.110 |
Why?
| Male | 8 | 2020 | 59639 | 0.110 |
Why?
| Urban Population | 1 | 2015 | 425 | 0.110 |
Why?
| Telephone | 1 | 2013 | 160 | 0.110 |
Why?
| Health Personnel | 1 | 2017 | 603 | 0.100 |
Why?
| United States | 3 | 2021 | 13272 | 0.100 |
Why?
| Certification | 1 | 2013 | 110 | 0.100 |
Why?
| Antidepressive Agents, Tricyclic | 1 | 2012 | 32 | 0.100 |
Why?
| Bipolar Disorder | 1 | 2014 | 207 | 0.100 |
Why?
| Retrospective Studies | 5 | 2021 | 13433 | 0.100 |
Why?
| Benzhydryl Compounds | 1 | 2012 | 61 | 0.100 |
Why?
| Faculty | 1 | 2013 | 133 | 0.100 |
Why?
| Acute Disease | 2 | 2015 | 984 | 0.100 |
Why?
| Nonprescription Drugs | 1 | 2012 | 69 | 0.100 |
Why?
| Radiography | 1 | 2013 | 888 | 0.100 |
Why?
| Depressive Disorder, Major | 1 | 2014 | 309 | 0.100 |
Why?
| Risk | 1 | 2013 | 890 | 0.100 |
Why?
| Universities | 1 | 2013 | 356 | 0.090 |
Why?
| Creatinine | 1 | 2012 | 510 | 0.090 |
Why?
| Drug Therapy, Combination | 1 | 2012 | 988 | 0.080 |
Why?
| Prospective Studies | 1 | 2020 | 6704 | 0.080 |
Why?
| Length of Stay | 1 | 2013 | 1077 | 0.080 |
Why?
| Weight Loss | 1 | 2012 | 663 | 0.080 |
Why?
| Patient Education as Topic | 1 | 2012 | 717 | 0.080 |
Why?
| Patient Readmission | 1 | 2013 | 691 | 0.080 |
Why?
| Risk Assessment | 1 | 2016 | 3213 | 0.070 |
Why?
| Hospitalization | 1 | 2015 | 1914 | 0.070 |
Why?
| Young Adult | 3 | 2016 | 11094 | 0.060 |
Why?
| Adolescent | 3 | 2016 | 18948 | 0.050 |
Why?
| Angiotensin Receptor Antagonists | 1 | 2021 | 93 | 0.050 |
Why?
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 228 | 0.050 |
Why?
| Primary Prevention | 1 | 2014 | 212 | 0.030 |
Why?
| Data Collection | 1 | 2014 | 667 | 0.030 |
Why?
| Quality of Life | 1 | 2022 | 2457 | 0.020 |
Why?
| Cross-Sectional Studies | 1 | 2021 | 4734 | 0.020 |
Why?
| Animals | 1 | 2012 | 34133 | 0.020 |
Why?
| Pregnancy | 1 | 2021 | 5854 | 0.020 |
Why?
| Coronary Artery Disease | 1 | 2015 | 695 | 0.020 |
Why?
| Databases, Factual | 1 | 2013 | 1287 | 0.020 |
Why?
| Age Factors | 1 | 2015 | 3114 | 0.020 |
Why?
| Prevalence | 1 | 2013 | 2442 | 0.020 |
Why?
| Cardiovascular Diseases | 1 | 2014 | 1859 | 0.010 |
Why?
| Risk Factors | 1 | 2014 | 9381 | 0.010 |
Why?
|
|
Anderson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|